COMMUNIQUÉS West-GlobeNewswire

QHSLab, Inc. Enhances Leadership Team with Dr. Marcos Sanchez-Gonzalez as New VP of Medical and Scientific Affairs

02/05/2024 - 14:30

WEST PALM BEACH, FL, May 02, 2024 (GLOBE NEWSWIRE) -- QHSLab, Inc. (the "Company") (OTCQB: USAQ), a leader in digital health and point-of-care technologies designed to empower clinicians with proactive, value-based [...]

Veru to Present at the GLP-1 Based Therapeutics Summit

02/05/2024 - 14:30

MIAMI, FL, May 02, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss, [...]

Wave Life Sciences First Quarter 2024 Financial Results Scheduled for May 9, 2024

02/05/2024 - 14:30

CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will [...]

IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share

02/05/2024 - 14:30

Reports record revenue of $17.6 million for the first quarter of 2024. Reports GAAP diluted EPS of $0.32 and non-GAAP diluted EPS of $0.36 for the first quarter of 2024. Reports first quarter of 2024 operating income of [...]

Longeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024

02/05/2024 - 14:03

MIAMI, May 02, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing regenerative medicines, today announced that it will report first quarter 2024 financial results [...]

STALICLA initiates U.S. Phase 3 enabling DDI study of STP7 (Mavoglurant) to treat cocaine use disorder

02/05/2024 - 14:01

Geneva, Switzerland, May 2, 2024 – STALICLA SA, a late-stage biotechnology company specializing in precision medicine for brain disorders, announces the First Patient First Visit (FPFV) for the company's drug-drug [...]

Mersana Therapeutics to Host First Quarter 2024 Conference Call on May 9, 2024

02/05/2024 - 14:00

CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs [...]

Vicinitas Therapeutics Appoints Adam Hughes as Chief Scientific Officer

02/05/2024 - 14:00

SOUTH SAN FRANCISCO, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Vicinitas Therapeutics, a biotechnology company advancing a proprietary targeted protein stabilization platform to develop novel therapeutics for cancer and [...]

Allarity Therapeutics’ Stenoparib Shows Clear Clinical Benefit and Achieves Significant Milestone with Early Conclusion of Phase 2 Trial in Advanced Ovarian Cancer

02/05/2024 - 14:00

Boston (May 2, 2024)—Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a clinical-stage pharmaceutical company dedicated to developing personalized cancer treatments, today announced the early [...]

EDAP to Announce First Quarter 2024 Financial Results on May 16, 2024

02/05/2024 - 14:00

Company to host conference call and webcast on Thursday, May 16 th at 8:30am EDT LYON, France, May 2, 2024 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today [...]

Intuity Medical’s POGO Automatic®, the First and Only FDA-Cleared Automatic Blood Glucose Monitor, Now Covered by Medicare Part B

02/05/2024 - 14:00

CMS establishes new Medicare coverage codes for the one-step automatic blood glucose monitor, expanding access to millions of seniors living with diabetes FREMONT, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Intuity [...]

PDS Biotech Appoints Stephan Toutain as Chief Operating Officer

02/05/2024 - 14:00

Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) PRINCETON, N.J., May 02, 2024 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy [...]

Shape Therapeutics Announces Appointment of Matt Valentino as Chief People Officer

02/05/2024 - 14:00

SEATTLE, May 02, 2024 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a leader at the convergence of AI and RNA editing to revolutionize genomic medicine, is pleased to announce the appointment of Matt Valentino [...]

Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial

02/05/2024 - 14:00

Partnership with Leading Biotech Company Enrolls 28% of Study Participants with 22x Greater Enrollment Velocity Compared to Traditional Brick-and-Mortar Clinical Trial Sites RESEARCH TRIANGLE PARK, N.C., May 02, 2024 ( [...]

iCAD to Report First Quarter 2024 Financial Results on May 15, 2024

02/05/2024 - 14:00

NASHUA, N.H., May 02, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc . (NASDAQ: ICAD), a global leader in clinically proven AI-powered cancer detection solutions, announced today it will release financial results for the first [...]

Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq’s Minimum Stockholders’ Equity Requirement

02/05/2024 - 14:00

Dallas, Texas, May 02, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products [...]

The Canadian Dermatology Association (CDA) Announces the Launch of the 2024 Shade Structure Grant Program

02/05/2024 - 14:00

Aiming to Combat Skin Cancer with Community Shade Initiatives OTTAWA, May 02, 2024 (GLOBE NEWSWIRE) -- The Canadian Dermatology Association (CDA) is thrilled to announce the return of the Shade Structure Grant Program, [...]

L’Association canadienne de dermatologie (ACD) annonce le lancement de l’édition 2024 de son Programme de subvention de structures ombrières

02/05/2024 - 14:00

Aider à prévenir les cancers de la peau par des initiatives destinées à créer de l’ombre dans les collectivités OTTAWA, 02 mai 2024 (GLOBE NEWSWIRE) -- L’Association canadienne de dermatologie (ACD) est ravie d’annoncer [...]

LifeMD Becomes the First Virtual Primary Care Provider to Elevate GLP-1 Patient Care with Real-time, At-Home Monitoring of Blood Pressure and Body Composition

02/05/2024 - 14:00

LifeMD and Withings Health Solutions partnership exemplifies the potential of digital health technology to transform virtual patient care and improve outcomes NEW YORK and BOSTON, May 02, 2024 (GLOBE NEWSWIRE) -- LifeMD [...]